In a first-of-its-kind study using advanced brain imaging techniques, a commonly used anti-psychotic medication was associated with potentially adverse changes in brain structure. This study was the first in humans to evaluate the effects of this type of medication on the brain using a gold-standard design: a double-blind, randomized, placebo-controlled trial. The study could have an immediate impact on clinical practice.

Source: Anti-psychotic medication linked to adverse change in brain structure

Categories: Misc....